Tech Company Financing Transactions

enGene Funding Round

enGene, based in Montreal QC, raised $10.9 million from Forbion Capital Partners, Fonds de solidarite FTQ and Lumira Capital .

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

7171 Frederick-Banting
Montreal QC, H4S 1Z9
Canada

Phone

(514) 332-4888

Website

www.engeneinc.com

Email Address

[email protected]

Overview

enGene is a biotechnology company developing a mucosal immunotherapy platform for the treatment of inflammatory bowel disease and diabetes.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chairman

Richard Glickman

        

Chief Executive Officer

Jason Hanson

        

Chief Scientific Officer

José Lora

        

Chief Technical Officer

Anthony Cheung

        

Browse more venture capital transactions:

Prev: 1/27/2015: TeachMate365 venture capital transaction
Next: 1/27/2015: Dizzion venture capital transaction

Share this article

About Our Venture Capital Transactions Database

Our team works diligently to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary